Research & Development



五O 《宋稗類抄》第一卷《遭際類》雲︰“陳了翁之父尚書,與潘良貴義榮之父交好。潘一日謂陳曰︰‘吾二人官職、年齒,種種相似,恨有一事不如公。’陳問之。潘曰︰‘公有三子,我乃無之。’陳曰︰‘吾有妾,已生子矣,可以奉借。他日生子,當即見還。’既而遣至,即了翁之母也。未幾,生良貴。後其母遂往來兩家。一母生二名儒,前所未有。”此事太通脫,今人所斷不為,而宋之賢者為之,且傳為佳話。高南阜太守題詩曰︰“贈妾生兒古人有,兒生還妾古人無。宋賢豁達竟如此,寄語人間小丈夫!”杭州馮山公先生,以春秋盧蒲瞥為齊之忠臣,雲︰“替莊公報仇,要滅崔氏,非慶封不可;欲輸心慶封,非易內不可。五倫中,君、父最大,夫、妻為小。盧顧大倫,故不顧小倫也。”其言甚創,人多怪之。余按東漢《獨行傳》︰犍為任永避王莽之亂,偽病青盲,妻淫于前,佯為不見。似山公之言,未嘗無證。168彩票官方客户端下载 全球彩票软件下载 注冊 2006-4-3qqcp·com全球彩票 二O

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo